Clinical Trial Update: A Study of S6G5T3 in the Treatment of Acne Vulgaris [Phase 3]

View source ↗

Summary

Phase 3 trial for S6G5T3 in acne vulgaris completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• S6G5T3

Snippet

Sponsor: Sol-Gel Technologies, Ltd. | Conditions: Acne Vulgaris | Phase 3 | Status: COMPLETED | Results posted: 2021-12-01